Bisphosphonate Therapy
- 1 January 1997
- journal article
- review article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 313 (1) , 17-22
- https://doi.org/10.1097/00000441-199701000-00004
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Prevention of early postmenopausal bone loss by risedronate: One year follow-up dataBone, 1995
- Histomorphometry from a three-year risedronate bone loss prevention studyBone, 1995
- Cyclical clodronate is effective in preventing postmenopausal bone loss: A comparative study with transcutaneous hormone replacement therapyJournal of Bone and Mineral Research, 1995
- Osteoporosis in severe congenital neutropenia treated with granulocyte colony‐stimulating factorBritish Journal of Haematology, 1995
- Recovery of serum calcium concentrations following acute hypocalcemia in patients with osteoporosis on long-term oral therapy with the bisphosphonate pamidronateJournal of Clinical Endocrinology & Metabolism, 1995
- Hypercalcemia and hyperosteolysis in vitamin D intoxication: Effects of clodronate therapyBone, 1994
- CD44 expression in human bone: A novel marker of osteocytic differentiationJournal of Bone and Mineral Research, 1994
- Effects of one-year cyclical treatment with clodronate on postmenopausal bone lossBone, 1993
- BisphosphonatesDrugs, 1991
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990